Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
IXHL Incannex Healthcare
3.500+0.300+9.37%
Close
02/07 16:00 ET
3.5000.0000.00%
Post Mkt Price 02/07 16:00 ET
High
3.500
Open
3.388
Turnover
6.61K
Low
3.360
Pre Close
3.200
Volume
1.94K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Top Premarket Decliners
08:00 AM EST, 01/30/2023 (MT Newswires) -- CN Energy Group (CNEY) shares slumped 52% on a planned public offering of its securities. Movano Health (MOVE) shares tumbled 31%, adding to Friday's losses
Incannex Healthcare Limited (NASDAQ:IXHL) Short Interest Update
Incannex Healthcare Limited (NASDAQ:IXHL – Get Rating) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 11,00
WYNN, MLCO and ALLO Are Among After Hour Movers
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersGT Biopharma (NASDAQ:GTBP) shares increased by 7.4% to $0.91 during Wednesday's after-market session. The market value of their outstanding shares is at $33.0 million. Science 37 Hldgs (NASDAQ:
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 80.0% to $2.16 during Wednesday's pre-market session. The company's market cap stands at $6.7 million. First Wave BioPharma (NASDAQ:FWBI) stock m
Why EHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Gainers Inpixon (NASDAQ:INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a
Incannex Healthcare Limited (NASDAQ:IXHL) Short Interest Up 25.9% in December
Incannex Healthcare Limited (NASDAQ:IXHL – Get Rating) was the recipient of a large growth in short interest in the month of December. As of December 30th, there was short interest totalling 14,600 s
Incannex Healthcare Begins Interim Analysis of Ongoing Anxiety Trial
12:22 AM EST, 01/18/2023 (MT Newswires) -- Incannex Healthcare (ASX:IHL) began an interim analysis of recent data from an ongoing clinical trial investigating the use of the pharmaceutical firm's psyc
Sector Update: Health Care Stocks Sinking With Broader Markets Wednesday
02:08 PM EST, 01/18/2023 (MT Newswires) -- Health care stocks were mostly lower Wednesday afternoon, with the NYSE Health Care Index falling 0.7% and the Health Care Select Sector SPDR Fund (XLV) down
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
Australian biopharma company developing therapeutic cannabinoid products and psychedelic medicines Incannex Healthcare (NASDAQ:IXHL) announced that its Phase 2 clinical trial assessing proprietary psi
Company Overview
More
Incannex Healthcare Ltd. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It operates through the following segments: Psychedelic Products, Cannabinoid Products, and Corporate. The Psychedelic Products segment is involved in the use of psychedelic medicine and therapies for the treatment of mental health disorders. The Cannabinoid Products segment focuses on the use of medicinal cannabinoid products. The Corporate segment consists of management of the organization, capital management, and management of resources. The company was founded on April 27, 2001 and is headquartered in Melbourne, Australia.
CEO： Mr. Joel Latham
Market： NASDAQ
Listing Date： 03/02/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet